Previous 10 | Next 10 |
Any potential coronavirus treatment or vaccine could run through ICON ( ICLR ), a large clinical-research organization (CRO) that helps pharmaceutical companies develop new medications, asserts Richard Moroney , editor of Dow Theory Forecasts . The company focuses on lat...
Investment Thesis Icon PLC 5-year share price performance. Source: TradingView. Icon ( ICLR ) looks like a solid investment opportunity in the contract research organization ("CRO") space, offering strong growth potential whilst being a little undervalued by the market, based on my anal...
The following slide deck was published by ICON Public Limited Company in conjunction with their 2020 Q2 earnings Read more ...
Image source: The Motley Fool. Icon PLC (NASDAQ: ICLR) Q2 2020 Earnings Call Jul 23, 2020 , 9:00 a.m. ET Operator Continue reading
ICON Public Limited Company (ICLR) Q2 2020 Earnings Conference Call July 23, 2020 9:00 AM ET Company Participants Steve Cutler – Chief Executive Officer Brendan Brennan – Chief Financial Officer Conference Call Participants Luke Sergott – Evercore Bob J...
Icon (NASDAQ: ICLR ) : Q2 Non-GAAP EPS of $1.20 misses by $0.20 ; GAAP EPS of $0.90 misses by $0.50 . More news on: ICON Public Limited Company, Earnings news and commentary, Healthcare stocks news, Read more ...
We recently reviewed mid-cap stocks with market values below $15 billion that were also generating solid operating momentum and boasting solid financial strength, suggests Richard Moroney ; here, the editor of Dow Theory Forecasts , discusses two clinical research firms that earn his long-te...
ICON plc , (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Virtual Healthcare Conference on...
ICON plc , (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the UBS Virtual Global Healthcare Conferenc...
ICON announces the appointment of Dr. Kristen K. Buck as the new Chief Medical Officer (CMO) ICON plc, (NASDAQ: ICLR) a leading global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today an...
News, Short Squeeze, Breakout and More Instantly...
Highlights Net business wins in the quarter of $2,579 million, an increase of 6.6% on quarter two 2023. Reflects a net book to bill in the quarter of 1.22, and a trailing twelve month net book to bill of 1.24. Closing backlog of $23.8 billion, an increase of 2.0% on quarter one 20...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that all resolutions at the Annual General Meeting of the company (AGM) held on July 23, 2024 were duly passed by shareholders. ICON also confirmed that following the conclus...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2024 with a number of leading business and industry awards recognising the company’s leadership position in the clinical research industry, in addi...